Clinical Trials Browser

SHR-1701 × Gastrointestinal × 90 days × Clear all

NCT07464756 2026-03-11

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Gastric Adenocarcinoma

NCT05671822 2026-02-12

Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer

Phase 2 Recruiting

Gastrointestinal

HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

NCT07311408 2025-12-31

SHR-2554

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms